News & Events about Bio Rad Laboratories Inc.
Stock Options Channel
1 year ago
Investors eyeing a purchase of Bio-Rad Laboratories Inc (BIO) stock, but tentative about paying the going market price of 375.00/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the August put ...
Stock Options Channel
1 year ago
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Dollar Tree Inc (DLTR), where a total volume of 56,921 contracts has been traded thus far today, a contract volume which is representative of approximately 5.7 million underlying ...
Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO Get Rating) have received an average recommendation of Buy from the six ratings firms that are currently covering the company, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a buy ...
Bio-Rad Laboratories (NYSE:BIO Get Rating) had its price objective hoisted by Credit Suisse Group from $640.00 to $680.00 in a report published on Friday, The Fly reports. Several other equities analysts also recently commented on BIO. Royal Bank of Canada began coverage on Bio-Rad ...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced that the companys management will participate in a fireside chat event during Citis 2023 Healthcare Services, MedTech, Tools & HCIT Conference on...